YDK-84688-09531
3 vaccinations
2 coded responses
20 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 080 / NJ
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 1 — Pfizer-BioNTech
- 2021-03-03
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-05
- 2021-03-06
-
2021-03-12
Survey response — day 7, dose 1MedDRA: Intermenstrual bleeding, Vaginal haemorrhage — Feeling: GoodFree text: Light vaginal bleeding/spotting which started on 3/5 and ended on 3/9. No idea if it was related but I never get mid cycle bleeding, so it was notable.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
-
2021-03-24
Dose 2 — Pfizer-BioNTech
-
2021-03-24
Health check-in — day 0, dose 2Feeling: Good · Site: Swelling · Chills, Joint pains, Muscle or body achesAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-03-30
- 2021-04-02
- 2021-04-07
- 2021-04-21
- 2021-04-30
- 2021-05-05
- 2021-06-23
- 2021-09-22
-
2021-10-28
Dose 3 — Pfizer-BioNTech
- 2021-12-05
- 2021-12-09
-
2022-01-27
Survey response — 3 months, dose 3MedDRA: Breast cancer — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Breast cancer diagnosisMedDRA releases: 2024-11 · check-in free text available
-
2022-01-27
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2022-01-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech | |
| 3 | 2021-10-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-27 | Unsuccessful |
Free text
Release 5 — day 7, dose 1
Systemic reaction (other): Light vaginal bleeding/spotting which started on 3/5 and ended on 3/9. No idea if it was related but I never get mid cycle bleeding, so it was notable.
Release 11 — 3 months, dose 3
Symptoms: Breast cancer diagnosis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breast cancer | · | · | ✓ |
| SRO | Intermenstrual bleeding | ✓ | ✓ | ✓ |
| SRO | Vaginal haemorrhage | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release